The prescribing information for cyanocobalamin injection states that vitamin B12 deficiency allowed to progress for longer than 3 months may produce permanent degenerative lesions of the spinal cord. The National Heart, Lung, and Blood Institute also describes complications that may be permanent. On folic acid, the label and a historical review differ in emphasis, and this guide does not resolve that.
What the label says about deficiency that progresses
The label states that vitamin B12 deficiency that is allowed to progress for longer than 3 months may produce permanent degenerative lesions of the spinal cord. It also states that patients with pernicious anemia should be informed that they will require monthly injections of vitamin B12 for the remainder of their lives. It continues that failure to do so will result in return of the anemia and in development of incapacitating and irreversible damage to the nerves of the spinal cord.
These are the label's words, reported here without recommendation. The last two statements are written for patients with pernicious anemia. Other groups are not addressed in the sentences cited. A licensed provider decides diagnosis, treatment and schedule.
What the National Heart, Lung, and Blood Institute says
In a patient information page, the institute states that vitamin B12 deficiency may cause serious complications, such as bleeding, infections, and problems with your brain or nerves that may be permanent. It also states that babies born to mothers who have vitamin B12 deficiency may have developmental delays and birth defects of the brain and spinal cord. This is general patient information from an NIH institute, not a trial or a review.
Folic acid: two emphases
Two sources address folic acid and low B12. Their wording differs.
| Question | What the source says |
|---|---|
| What does the prescribing information say? | The label says patients should be warned about the danger of taking folic acid in place of vitamin B12, because folic acid may prevent anemia but allow progression of subacute combined degeneration. |
| What does the historical review say? | A historical review concluded that the historical record does not provide compelling evidence that folic acid can potentially cause neurologic complications among those with low vitamin B12 status. |
The first is a statement in a label. The second is the conclusion of a historical review, described here only as far as its abstract goes. Neither sentence cited gives a folic acid dose or a length of use. The label stresses a danger. The review stresses that the evidence it examined is not compelling. This guide does not decide between them.
What the Cochrane review reported about outcomes
A Cochrane review of oral versus intramuscular (IM) vitamin B12 states that no trial reported on clinical signs and symptoms of vitamin B12 deficiency, health-related quality of life, or acceptability of the treatment scheme. That is a statement about what the trials reported. It is not a finding about untreated deficiency, and the sentence cited does not give doses, trial lengths or participants.
What this does not tell you
These sources do not say how likely any consequence is, or how quickly it develops, for a given person. The Cochrane statement is about outcomes that trials did not report, so it does not measure what happens without treatment. The pernicious anemia statements are the label's wording for that condition. The folic acid question is shown here as two sources with different emphasis, not as a settled answer. None of this diagnoses a deficiency or sets a treatment, dose or schedule. A licensed provider decides those.